|
|
|
|
|
|
|
|
|
|
|
|
Gulf View Walk In Clinic gets H1N1 Swine Flu Intranasal Vaccine Supply Novel H1N1 2009 Monovalent Vaccine Live, Intranasal is recommended for the active immunization of healthy individuals 2 to 49 years of age against Influenza disease caused by pandemic H1N1 2009 Virus. Gulf View Walk In has two offices: New Port Richey office at 6329 State Road 54, next to Barn Hills Restaurant (Tel. 727-844-5555) and Spring Hill office at 11123 County Line Road, across from Spring Hill Regional Hospital (352-666-5555). Gulf View Walk In Clinic receives its first supply of Intranasal H1N1 Vaccine. Dr. Dhaliwal states we are ready to immunize as many people as possible. If needed and have abundant vaccine supply we will open both of our offices from 8 AM to 8 PM seven days. Presently there is limited supply of vaccine. In the same token, not that many patients are keen to take intranasal vaccine due to the fear of side effects. Since the vaccine is supplied free of cost, only administration cost of $20 (equivalent to Medicare allowable) will be charged to all Non-Medicare patients. Medicare assignment is accepted. Most of the Medicare HMO's may reimburse the patients. Dr. Dhaliwal took the first intranasal spray to his nostrils and he gave second to his 12 year old son who happened to be in the office with school being closed. Dr. Dhaliwal feels comfortable recommending this live attenuated H1N1 Vaccine for all healthy individuals (2 to 49 years). ----------------------DOSAGE AND ADMINISTRATION----------------------- Based on currently available information the vaccination regimen is as follows: Age Group Dosage Schedule Children (2-9 years) 2 doses (0.2 mL each, approximately 1 month apart) Children, adolescents 1 dose (0.2 mL) and adults (10-49 years) Each 0.2 mL dose is administered as 0.1 mL per nostril. Prefilled single-dose intranasal sprayer containing 0.2 mL suspension. -------------------------------CONTRAINDICATIONS------------------------------ Hypersensitivity to eggs, egg proteins, gentamicin, gelatin or arginine or life threatening reactions to previous influenza vaccination. Concomitant aspirin therapy in children and adolescents. -----------------------WARNINGS AND PRECAUTIONS----------------------- Do not administer Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal to children <24 months of age because of increased risk of hospitalization and wheezing. Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal should not be administered to any individuals with asthma or children < 5 years of age with recurrent wheezing because of the potential for increased risk of wheezing post vaccination. If Guillain-Barrι syndrome has occurred with any prior influenza vaccination, the decision to give Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal should be based on careful consideration of the potential benefits and risks. Administration of Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal, a live virus vaccine, to immunocompromised persons should be based on careful consideration of potential benefits and risks. Safety has not been established in individuals with underlying medical conditions predisposing them to wild-type influenza infection complications.
------------------------------ADVERSE REACTIONS------------------------------- Information is based on studies conducted with seasonal trivalent Influenza Vaccine Live, Intranasal (FluMist) manufactured by MedImmune. Most common adverse reactions (≥ 10% in FluMist and at least 5% greater than in control) are runny nose or nasal congestion in all ages, fever >100°F in children 2-6 years of age, and sore throat in adults. To report SUSPECTED ADVERSE REACTIONS, contact MedImmune at 1-877-633-4411 or VAERS at 1-800-822-7967.
------------------------------DRUG INTERACTIONS------------------------------- Antiviral agents active against influenza A and/or B: Do not administer Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal until 48 hours after antiviral cessation. Antiviral agents should not be administered until 2 weeks after Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal administration unless medically necessary. -----------------------USE IN SPECIFIC POPULATIONS------------------------ Safety and effectiveness of Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal have not been studied in pregnant women or nursing mothers. |
